-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Axsome Therapeutics, Raises Price Target to $202

Benzinga·11/06/2025 16:47:46
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $200 to $202.